Steven Cohen Embecta Corp. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.13 - $14.6 $3.73 Million - $5.37 Million	-367,975 Reduced 97.01%	11,325 $141,000
Q1 2024 May 15, 2024	SELL	$12.35 - $19.33 $731,120 - $1.14 Million	-59,200 Reduced 13.5%	379,300 $5.03 Million
Q4 2023 Feb 14, 2024	BUY	$12.87 - $19.09 $5.64 Million - $8.37 Million	438,500 New	438,500 $8.3 Million
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $4.3 Million - $6.12 Million	-199,300 Reduced 44.45%	249,020 $5.38 Million
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $10.3 Million - $14.7 Million	448,320 New	448,320 $12.6 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.